SUM-159 Blog

December 8, 2017May 16, 2018 - by Steve Ethier

Post your comments or questions on the SUM-159 cell line here Back Home Share this: Share on X (Opens in new window) X Share on

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

About Steve Ethier

I am the developer of the SUM breast cancer cell lines, and the SUM Line Knowledge Base. I am retired from the Medical Universithy of South Carolina and I am the founder of Sextant Oncology LLC

View all posts by Steve Ethier →

Copy number data for candidate oncogenes in each cell line
Point mutation data for genes recurrently mutated in cancer
Genome-wide expression data
Genome-scale shRNA interference screen data for all cell lines with hit data displayed on KEGG pathways
Genome-scale CRISPR screen data for all cell lines with hit data displayed on KEGG pathways
Narrative summary describing how each SUM cell line was developed and descriptions of originating sources and characteristics of 40 other breast cancer cell lines
Drug sensitivity data from the Genomics of Drug Sensitivity in Cancer data base, linked to a data mining tool for each cell line in the database
A Bibliography of peer-reviewed papers containing data obtained with each SUM cell line

Related Posts

Why it is important for investigators to obtain cell lines from the originating source

The Curious Case of FGFR1

CRISPR versus RNAi based screens: Which are more useful when using the data mining tools?

About Steve Ethier